183 related articles for article (PubMed ID: 29443735)
21. The clinical significance of interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.
Tang XZ; Zhou XG; Zhang XG; Li GS; Chen G; Dang YW; Huang ZG; Li MX; Liang Y; Yao YX; Chen XY; Rong MH; Huang SN
Cancer Biomark; 2020; 29(1):111-124. PubMed ID: 32623386
[TBL] [Abstract][Full Text] [Related]
22. Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis.
Chen W; Liao L; Lai H; Yi X; Wang D
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1397-1408. PubMed ID: 32067095
[TBL] [Abstract][Full Text] [Related]
23. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
Foteinou E; Kontos CK; Giotakis AI; Scorilas A
Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
[TBL] [Abstract][Full Text] [Related]
24. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.
Ayaz L; Görür A; Yaroğlu HY; Ozcan C; Tamer L
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1499-506. PubMed ID: 23817697
[TBL] [Abstract][Full Text] [Related]
27. Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.
Mo BY; Li GS; Huang SN; Wei ZX; Su YS; Dai WB; Ruan L
Med Sci Monit; 2020 Dec; 26():e928185. PubMed ID: 33361747
[TBL] [Abstract][Full Text] [Related]
28. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
29. Competing endogenous RNA network analysis of CD274, IL‑10 and FOXP3 co‑expression in laryngeal squamous cell carcinoma.
Sun J; Lian M; Ma H; Wang R; Ma Z; Wang H; Zhai J; Meng L; Feng L; Bai Y; Cui X; Fang J
Mol Med Rep; 2018 Mar; 17(3):3859-3869. PubMed ID: 29257349
[TBL] [Abstract][Full Text] [Related]
30. Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer.
Chen J; Luo J; He J; Jiang X; Jiang N; Yang C; Zhong S
Biomed Res Int; 2023; 2023():1733100. PubMed ID: 36718148
[TBL] [Abstract][Full Text] [Related]
31. Analysis of gene expression profiling variations induced by hsa‑miR‑145‑5p‑overexpression in laryngeal squamous cell carcinoma cell line Tu‑177.
Ding Y; Wu Y; Gao W; Zhang C; Zhao Q; Guo H; Qu X; Wen S; Wang B
Mol Med Rep; 2017 Nov; 16(5):5863-5870. PubMed ID: 28849105
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma.
Pi JT; Lin Y; Quan Q; Chen LL; Jiang LZ; Chi W; Chen HY
Med Oncol; 2013 Dec; 30(4):613. PubMed ID: 24005809
[TBL] [Abstract][Full Text] [Related]
33. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
34. Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma.
Zou Y; Fang F; Ding YJ; Dai MY; Yi X; Chen C; Tao ZZ; Chen SM
Mol Med Rep; 2016 Oct; 14(4):3517-24. PubMed ID: 27572051
[TBL] [Abstract][Full Text] [Related]
35. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
Wang JL; Wang X; Yang D; Shi WJ
Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
Zhou G; Zhang S; Jin M; Hu S
BMC Cancer; 2022 Jun; 22(1):667. PubMed ID: 35715770
[TBL] [Abstract][Full Text] [Related]
38.
Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
[TBL] [Abstract][Full Text] [Related]
39. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of a panel of biomarkers related to protein phosphatase 2A between laryngeal squamous cell carcinoma tissues and adjacent normal tissues.
Wang HY; Yuan H; Liu JH; Wang BL; Xu KL; Huang P; Lin ZH; Xu LH
J Zhejiang Univ Sci B; 2019 Sept.; 20(9):776-780. PubMed ID: 31379147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]